171 related articles for article (PubMed ID: 21083336)
1. DBS: a UK (MHRA) regulatory perspective.
Beharry M
Bioanalysis; 2010 Aug; 2(8):1363-4. PubMed ID: 21083336
[No Abstract] [Full Text] [Related]
2. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
Wang L; Zeng Z; Emmons G
Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
[TBL] [Abstract][Full Text] [Related]
3. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
Denniff P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
[TBL] [Abstract][Full Text] [Related]
4. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
Abu-Rabie P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
[TBL] [Abstract][Full Text] [Related]
5. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system.
Heinig K; Wirz T; Gajate-Perez A
Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
Spooner N; Lad R; Barfield M
Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
[TBL] [Abstract][Full Text] [Related]
7. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
[TBL] [Abstract][Full Text] [Related]
8. Implementing DBS methodology for the determination of Compound A in monkey blood: GLP method validation and investigation of the impact of blood spreading on performance.
Fan L; Lee J; Hall J; Tolentino EJ; Wu H; El-Shourbagy T
Bioanalysis; 2011 Jun; 3(11):1241-52. PubMed ID: 21649500
[TBL] [Abstract][Full Text] [Related]
9. Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practices.
Evans CA; Bruce C; Emmons GT; Gallenberg L; Ji QC; Kinter LB; Musvasva E; Wickremsinhe E
Bioanalysis; 2010 Aug; 2(8):1355-9. PubMed ID: 21083334
[No Abstract] [Full Text] [Related]
10. The application of capillary microsampling in GLP toxicology studies.
Verhaeghe T; Dillen L; Stieltjes H; Zwart L; Feyen B; Diels L; Vroman A; Timmerman P
Bioanalysis; 2017 Apr; 9(7):531-540. PubMed ID: 28300424
[TBL] [Abstract][Full Text] [Related]
11. Direct analysis in real time coupled with dried spot sampling for bioanalysis in a drug-discovery setting.
Crawford E; Gordon J; Wu JT; Musselman B; Liu R; Yu S
Bioanalysis; 2011 Jun; 3(11):1217-26. PubMed ID: 21649498
[TBL] [Abstract][Full Text] [Related]
12. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
[TBL] [Abstract][Full Text] [Related]
13. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
[TBL] [Abstract][Full Text] [Related]
14. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
[TBL] [Abstract][Full Text] [Related]
15. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
[TBL] [Abstract][Full Text] [Related]
16. Connecting strategies on dried blood spots.
Abbott R; Smeraglia J; White S; Luedtke S; Brunet L; Thomas E; Globig S; Timmerman P
Bioanalysis; 2010 Nov; 2(11):1809-16. PubMed ID: 21083488
[No Abstract] [Full Text] [Related]
17. Assessment of DBS technology for the detection of therapeutic antibodies.
Prince PJ; Matsuda KC; Retter M; Scott G
Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic considerations as to when to use dried blood spot sampling.
Emmons G; Rowland M
Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
[TBL] [Abstract][Full Text] [Related]
19. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
Kehler JR; Bowen CL; Boram SL; Evans CA
Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
[TBL] [Abstract][Full Text] [Related]
20. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
Liang X; Jiang H; Chen X
Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
